Søgning på udtrykket 'hepatitis' giver 118 resultater
Dokumenter [17]
Sider [4]
Kalender [55]
Nyt fra tidsskrifterne [+20]
Aktuelle smitsomme sygdomme [+20]
Dokumenter [17]
National guideline udarbejdet af en arbejdsgruppe nedsat af medlemmer fra Dansk Selskab for Infektionsmedicin og medlemmer fra Dansk Selskab for Gastroenterologi og Hepatologi.
National guideline udarbejdet af en arbejdsgruppe nedsat af medlemmer fra Dansk Selskab for Infektionsmedicin og medlemmer fra Dansk Selskab for Gastroenterologi og Hepatologi.
Omhandler biologiske og målrettede syntetiske lægemidler (BMSL) til patienter i forhold til risiko for tuberkulose (TB), Humant Papillom Virus (HPV), Hepatitis B og C (HBV og HCV), Varicella Zoster Virus (VZV), Herpes Simplex Virus (HSV), Cytomegalovirus (CMV), Epstein Barr Virus (EBV) og Humant Immundefekt Virus (HIV) og øvrige infektioner.
Vejledningen er udarbejdet af repræsentanter fra Dansk Selskab for Gastroenterologi og Hepatologi (DSGH), Dansk Reumatologisk Selskab (DRS), Dansk Dermatologisk Se…
Diagnostik, behandling og forebyggelse af infektion med hepatitis A virus (HAV)
Forfattere: Jan Gerstoft, Nina Weis, Terese L. Katzenstein (Dansk Selskab for Infektionsmedicin), Anders Nyboe Andersen og Jens Fedder (Dansk Fertilitetsselskab).
Udarbejdet af en arbejdsgrupper bestående af medlemmer fra Dansk Selskab for Infektionsmedicin og Dansk Transplantationsselskab
Revideret september 2020. Arbejdsgruppen bestod af Suzanne Lunding (formand), Peer Brehm Christensen, Christian Erikstrup, Terese L. Katzenstein, Henrik Krarup, Alex Lund Laursen, Birgitte Mørn og Nina Weis
Bl.a. om HIV, hepatitis, resistente bakterier og immundefekt
Bl.a. om HIV, hepatitis, influenza og CNS infektioner
Bl.a. om HIV, hepatitis, cystisk fibrose og nye guidelines
Bl.a. om sygdom efter udlandsrejse, resistens og kroniske virale infektioner
Bilag til Retningslinjer for screening og profylakse før behandling med biologiske lægemidler (2023)
Sider [4]
…Erichsen, Rikke Krogh-Madsen, Toke Barfod, Ulla Balslev, Lotte Ebdrup, Lars Toft Nielsen, Jon Holler
Gastrointestinale infektioner:
Karina Frahm Kirk (tovholder), Morten Helms, Merete Storgaard, Janne Fuglsang Hansen, Mike Zangenberg
Hepatitis:
Akut viral hepatitis:
Carsten Shade Larsen (tovholder) og Nina Weis.
Hepatitis A (2013),
Hepatitis elimination i Danmark:
Anne Øvrehus (tovholder), Peer Brehm Christensen, Nina Weis, Britta Tarp, Lone Mygind
National Strate…
…
Se Kursus i CNS-infektioner 2024.
Sted.
Aalborg Universitets Hospital.
Delkursusledelse.
Jakob Bodilsen og Lars Omland.
Tidligere kurser.
11. og 12. april 2018.
9. og 10 september 2021.
Gastroenterologiske infektioner og kronisk hepatitis:
Dato for næste kursus
2026:
Sted
Odense Universitetshospital
Delkursusledelse
Lone Mygind, Micha Jepsen og Belinda Mössner
Tidligere kurser
4. og 5. december 2023
3. og 4. december 2020
HIV-infektion:
Næste kursus
Ef…
…ogiske oversigter (slides).
www.natap.org/. National AIDS Treatment Advocacy Project ? en New York State non-profit NGO ledet af Jules Levin (som selv lever med Hiv og hepatitis). God side, hvis man mangler slides/figurer/tabeller fra studier præsenteret på senest afholdte konferencer kommer ofte med referat (inklusive Jules Levins fortolkning ud fra et patient/aktivist perspektiv).
www.clinicaloptions.com/HIV.aspx. Et andet website for opdateringer og sammendrag af konferencer (slides).
Professor Henrik Nielsen kommenterer: I disse år sker et paradigmeskift i behandlingen af kronisk hepatitis C virus infektionen. Mange direkte virkende lægemidler er i afprøvning og med lovende resultater. Snart er interferon-baseret terapi ikke absolut nødvendig, mens oral terapi af kort varighed synes indenfor rækkevidde. Samtidigt er bivirkninger ved de nye lægemidler hidtil beskrevet som milde og sjældne. Kombination af sofosbuvir og ledipasvir i samme tablet bliver muligvis den første effektive…
Professor Nina Weis kommenterer: Kronisk hepatitis B, forårsaget af forekomst af hepatitis B virus i blodet i > 6 måneder, kan klinisk manifestere sig fra asymptomatisk til fibrose, cirrose og hepatocellulært carcinom.
Trods forekomst af en effektiv vaccine i mere end 40 år, lever 296 millioner mennesker globalt med kronisk hepatitis B, heraf estimerede 14.500 i Danmark. Aktuelt er eneste behandlingstilbud (ofte livslang) antiviral terapi.
Denne artikel gennemgår naturhistorien, kendte og nye biomark…
Kalender [55]
4. juni 2025, Barcelona, Spanien
4. juni 2025, Barcelona, Spanien
10. juni, Nielsine Nielsen Auditoriet, Panum, København
14. maj, Auditorium 3 og 4, Hvidovre Hospital
4. december 2023, Odense Universitetshospital
27. oktober 2023, Vandrehal lokale 3, Hvidovre Hospital
25. september 2023, Hvidovre Hospital
7. juni 2023, Rom, Italien
2. juni 2023, Auditorium 3 og 4, Hvidovre Hospital
26. oktober 2022, Auditorium 3 and 4, Hvidovre Hospital
17. juni 2022, Auditorium 3+4, Hvidovre Hospital
10. maj 2022, Auditorium 3+4, Hvidovre Hospital
3. december 2020, Hvidovre Hospital
28. oktober 2020, Paris, Frankrig
17. september 2020, Auditorium 3-4, Hvidovre Hospital
25. november 2019, Auditorium 3 og 4, Hvidovre Hospital
25. september 2019, London, England
11. september 2019, DGI-byen, København
21. juli 2019, Mexico City, Mexico
22. maj 2019, Rom, Italien
10. maj 2019, Auditorium 3 og 4, Hvidovre Hospital
15. februar 2019, Auditorium, University of Southern Denmark, J. B. Winsløws Vej 25, Odense
24. januar 2019, Aarhus Universitetshospital
28. november 2018, Hvidovre Hospital
30. maj 2018, Rom, Italien
4. maj 2018, Hindsgavl, Middelfart
9. april 2018, Amsterdam, Holland
27. februar 2018, Hvidovre Hospital
12. december 2017, Auditorium 3 og 4, Hvidovre Hospital
14. september 2017, IDA Mødecenter, Kalvebod Brygge 31, 1560 København V
30. maj 2017, Hvidovre Hospital
13. oktober 2016, Auditoriet, Syddansk Universitet
25. maj 2016, Rom, Italien
3. juni 2015, Barcelona, Spanien
24. marts 2015, Auditorium 3+4, Hvidovre Hospital
13. november 2014, Auditorium 3-4, Hvidovre Hospital
24. oktober 2014, Rigshospitalet
9. oktober 2014, Frankfurt, Tyskland
18. juli 2014, Aud. 3 og 4, Hvidovre Hospital, Kettegård Allé 30, 2650 Hvidovre
5. juli 2014, Sigtuna, Sverige
23. maj 2014, Aud. 3 og 4, Hvidovre Hospital, Kettegård Allé 30, 2650 Hvidovre
1. maj 2014, Berlin, Tyskland
26. marts 2014, Barcelona, Spanien
30. juni 2013, Kuala Lumpur, Malaysia
20. marts 2013, Rom, Italien
3. marts 2013, Atlanta, Georgia, USA
25. oktober 2012, Danmarks Medie- og Journalisthøjskole
18. oktober 2012, Berlin, Tyskland
7. november 2011, Auditorium 93, Rigshospitalet
24. maj 2011, Rigshospitalet, København
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se
flere resultater her?
BMC Infectious Diseases
25.07.2024
. Abstract. . Background and aims. Numerous HBeAg-positive chronic hepatitis B (CHB) patients with persistently normal ALT have significant liver histopathology. It is imperative to identify true “immune tolerant” patients. We aimed to evaluate the liver histopathology features of HBeAg-positive CHB patients with normal ALT and the incidence of liver cirrhosis and HCC in CHB patients during follow-up. . …
Journal of Medical Virology
24.07.2024
Journal of Medical Virology, Volume 96, Issue 7, July 2024.
BMC Infectious Diseases
24.07.2024
. Abstract. . Background and aims. Numerous HBeAg-positive chronic hepatitis B (CHB) patients with persistently normal ALT have significant liver histopathology. It is imperative to identify true “immune tolerant” patients. We aimed to evaluate the liver histopathology features of HBeAg-positive CHB patients with normal ALT and the incidence of liver cirrhosis and HCC in CHB patients during follow-up. . …
Journal of Medical Virology
23.07.2024
Journal of Medical Virology, Volume 96, Issue 7, July 2024.
Clinical Infectious Diseases
19.07.2024
Abstract . Background . Hepatitis C virus (HCV) reinfection rates are substantially higher than primary infection rates among men who have sex with men (MSM) with human immunodeficiency virus (HIV) in European cohorts. The behaviors mediating this high rate of transmission among MSM are poorly characterized.Methods . We performed a prospective cohort study in New York City (NYC) of MSM with HIV who cleared HCV to determine the incidence of and risk factors for HCV reinfection. We assessed the risk behaviors…
Emerg Microbes Infect
19.07.2024
Volume 13, Issue 1, December 2024 .
Journal of Medical Virology
18.07.2024
Journal of Medical Virology, Volume 96, Issue 7, July 2024.
Journal of Medical Virology
17.07.2024
Journal of Medical Virology, Volume 96, Issue 7, July 2024.
Journal of Infectious Diseases
14.07.2024
Abstract . Background . Approximately 296 million people suffer from chronic hepatitis B (CHB) caused by hepatitis B virus (HBV). Current standard treatment, nucleos(t)ide analogs, are not efficient enough to eradicate HBV from the hepatocytes. Thus, developing new drugs for CHB is desired to achieve complete cure.Methods . Here we established a novel HBV reporter system, HBV-HiBiT-PS2, to screen new drugs for CHB. HBV-HiBiT-PS2 was constructed by introducing a HiBiT-tag at the 5’-end of PreS2 and introdu…
PLoS One Infectious Diseases
13.07.2024
by Bantie Getnet Yirsaw, Muluken Chanie Agimas, Gebrie Getu Alemu, Tigabu Kidie Tesfie, Nebiyu Mekonnen Derseh, Habtamu Wagnew Abuhay, Meron Asmamaw Alemayehu, Getaneh Awoke Yismaw . Introduction Hepatitis B virus (HBV) is one of the major public health problems globally and needs an urgent response. It is one of the most responsible causes of mortality among the five hepatitis viruses, and it affects almost every class of individuals. Different studies were conducted on the prevalence of HBV among pregnan…
Journal of Medical Virology
11.07.2024
Journal of Medical Virology, Volume 96, Issue 7, July 2024.
PLoS One Infectious Diseases
11.07.2024
by Gemeda Wakgari Kitil, Abiy Tasew Dubale, Adamu Ambachew Shibabaw, Alex Ayenew Chereka . Background Hepatitis B virus infection remains a significant public health concern globally, particularly among healthcare workers, including health science students who are at high risk due to their exposure to infected patients and contaminated medical equipment. In Ethiopia, where the burden of HBV infection is substantial, preventive practices among health science students are critical for minimizing transmission…
PLoS One Infectious Diseases
10.07.2024
by Nadin Younes, Hiam Chemaitelly, Parveen Banu Nizamuddin, Tasneem Al-Hamad, Marah Abdallah, Hadi M. Yassine, Laith J. Abu-Raddad, Gheyath K. Nasrallah . Background Hepatitis A virus (HAV) is the predominant cause of acute viral hepatitis worldwide; however, data on HAV antibody prevalence (seroprevalence) among migrant populations are limited. This study aimed to investigate HAV seroprevalence among Qatar’s migrant craft and manual workers (CMWs), constituting approximately 60% of the country’s popul…
Journal of Infectious Diseases
8.07.2024
Abstract . Background . The change of serum hepatitis B surface antigen (HBsAg) during treatment are associated with HBsAg loss. However, little is known about the trajectory patterns of HBsAg in early treatment and their relationship with subsequent HBsAg loss. This study aimed to identify trajectories of HBsAg in children with HBeAg-positive chronic hepatitis B (CHB) and investigate the association between trajectory patterns and HBsAg loss.Methods . A retrospective study was conducted on 166 treatment-na…
BMC Infectious Diseases
4.07.2024
. Abstract. . Background. Healthcare Workers (HCWs) are susceptible to hepatitis B virus (HBV) infection and are advised to receive vaccination. However, vaccination rates remain low in developing countries. There is little data concerning Hepatitis B (HepB) vaccination and information regarding HBV knowledge among HCWs in Cambodia. This study aimed to evaluate the knowledge of HBV infection, HepB vaccine, and vaccination…
Journal of Medical Virology
4.07.2024
Journal of Medical Virology, Volume 96, Issue 7, July 2024.
BMJ Open
3.07.2024
. Introduction. Despite universal access to government-funded direct-acting antivirals (DAAs) in 2016, the rate of hepatitis C treatment uptake in Australia has declined substantially. Most hepatitis C is related to injecting drug use; reducing the hepatitis C burden among people who inject drugs (PWID) is, therefore, paramount to reach hepatitis C elimination targets. Increasing DAA uptake by PWID is important for interrupting transmission and reducing incidence, as well as reducing morbidity and mortality…
Lancet Microbe
2.07.2024
This study revealed a high SVR rate in Benin among individuals treated for HCV with sofosbuvir–velpatasvir, including those with highly diverse viral genotypes. Further studies of treatment effectiveness in genotypes 2d and 2b are indicated.
BMC Infectious Diseases
2.07.2024
. Abstract. . Background. Healthcare Workers (HCWs) are susceptible to hepatitis B virus (HBV) infection and are advised to receive vaccination. However, vaccination rates remain low in developing countries. There is little data concerning Hepatitis B (HepB) vaccination and information regarding HBV knowledge among HCWs in Cambodia. This study aimed to evaluate the knowledge of HBV infection, HepB vaccine, and vaccination…
BMJ Open
1.07.2024
. Objectives. Hepatitis C virus (HCV) infection poses a global health challenge. By the end of 2021, the WHO estimated that less than a quarter of global HCV infections had been diagnosed. There is a need for a public health tool that can facilitate the identification of people with HCV infection and link them to testing and treatment, and that can be customised for each country. . Methods. We derived and validated a risk score to identify people with HCV in Egypt and demonstrated its utility. Using data f…
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se
flere resultater her?
Eurosurveillance latest updates
26.07.2024
. Introduction. Obtaining epidemiological data on chronic hepatitis C virus (HCV) infection is essential to monitor progress towards the hepatitis C elimination targets. . . Aim. We aimed to estimate the prevalence of chronic HCV and the seroprevalence of HCV in the adult general population in Estonia. . . Methods. This cross-sectional study, conducted between 12 July and 6 December 2022, included anonymised residual sera collected prospectively from patients 18 years and older visiting a general prac…
Eurosurveillance latest updates
26.07.2024
. Introduction. A national study from 2006 to 2008 showed a high antibody prevalence of 3.2% against hepatitis C virus (HCV) in Romania, but more recent epidemiological data on hepatitis C prevalence are lacking. . . Aim. We aimed to estimate the current prevalence of HCV antibodies (anti-HCV) and chronic HCV infection in the general adult population in Romania, as a crucial element in monitoring progress towards eliminating hepatitis C. . . Methods. We used anonymised leftover sera from a SARS-CoV-2 …
Eurosurveillance latest updates
26.07.2024
.
Morbidity and Mortality Weekly Report (MMWR)
25.07.2024
This report describes vaccination efforts to eliminate mother-to-child hepatitis B.
Eurosurveillance latest updates
20.07.2024
. Background. People who use drugs (PWUD) are a key target population to reduce the burden of hepatitis C virus (HCV) infection. . . Aim. To assess risk factors and temporal trends of active HCV infection in PWUD in Madrid, Spain. . . Methods. We conducted a retrospective study between 2017 and 2023, including 2,264 PWUD visiting a mobile screening unit. Data about epidemiology, substance use and sexual risk behaviour were obtained through a 92-item questionnaire. HCV was detected by antibody test, fo…
Eurosurveillance latest updates
20.07.2024
. Background. Active follow-up of chronic hepatitis C notifications to promote linkage to care is a promising strategy to support elimination. . . Aim. This pilot study in Victoria, Australia, explored if the Department of Health could follow-up on hepatitis C cases through their diagnosing clinicians, to assess and support linkage to care and complete data missing from the notification. . . Methods. For notifications received between 1 September 2021 and 31 March 2022 of unspecified hepatitis C cases…
Eurosurveillance latest updates
14.06.2024
. Background. Awareness of transfusion-transmitted hepatitis E raised in recent years led to the mandatory testing of blood donations in some European countries for hepatitis E virus (HEV) RNA. However, little is known about the epidemiology of HEV infections. . . Aim. To and describe and analyse the epidemiology of HEV infections in blood donors in Germany. . . Methods. Data from routine testing of therapeutic blood products donated between January 2015 and December 2022 at the Uni.Blutspendedienst O…
Morbidity and Mortality Weekly Report (MMWR)
31.05.2024
This report describes hepatitis C viral clearance proportions among people with hepatitis C by state.
Eurosurveillance latest updates
26.05.2024
An outbreak of hepatitis A is ongoing in Portugal, with 71 confirmed cases from 7 October 2023 to 24 April 2024. Most cases are male, aged 18–44 years, with many identifying as men who have sex with men (MSM) and reported as suspected sexual transmission. Phylogenetic analysis identified the subgenotype IA, VRD 521–2016 strain, last observed in an MSM-associated multi-country outbreak in 2016 to 2018. We wish to alert colleagues in other countries to investigate potential similar spread. .
Eurosurveillance latest updates
24.05.2024
An outbreak of hepatitis A is ongoing in Portugal, with 71 confirmed cases from 7 October 2023 to 24 April 2024. Most cases are male, aged 18–44 years, with many identifying as men who have sex with men (MSM) and reported as suspected sexual transmission. Phylogenetic analysis identified the subgenotype IA, VRD 521–2016 strain, last observed in an MSM-associated multi-country outbreak in 2016 to 2018. We wish to alert colleagues in other countries to investigate potential similar spread. .
Medscape Infectious Diseases
15.05.2024
The U.S. drug regulator has declined to approve expanded use of Dynavax Technologies' hepatitis B vaccine in a section of patients, citing insufficient data over destruction. . Reuters Health Information
Medscape Infectious Diseases
24.04.2024
Although annual incidence decreased from 2.5 million in 2019 to 2.2 million in 2022, the WHO considers it to be high. . Medscape Medical News
Medscape Infectious Diseases
8.04.2024
While the hepatitis E virus causes tens of thousands of deaths each year, data suggest that a vaccine approved in China has long-term efficacy. . Medscape Medical News
Morbidity and Mortality Weekly Report (MMWR)
16.02.2024
This report describes Correctional Health Services and LA County Jail's response to a confirmed case of Hepatitis A in a person who is incarcerated.
Medscape Infectious Diseases
1.12.2023
At least 450 patients at Mass General Brigham, Salem Hospital, near Boston are at risk of HIV and hepatitis infection, according to a lawsuit claiming negligent intravenous medication administration. . Medscape Medical News
Medscape Infectious Diseases
11.11.2023
A scientist whose work was key to identifying, studying, and finding treatments for this life-threatening virus discusses the scientific journey and challenges that persist. . Knowable Magazine
Morbidity and Mortality Weekly Report (MMWR)
1.11.2023
CDC reports on CDC recommendations for hepatitis C testing among perinatally exposed infants and children in the United States in 2023.
Medscape Infectious Diseases
20.10.2023
Despite ongoing hostilities, healthcare professionals take mobile clinics to their fellow Ukrainians, as the battle extends to fighting the country's high levels of hepatitis C. . Medscape Medical News
Morbidity and Mortality Weekly Report (MMWR)
19.10.2023
This report describes deaths related to hepatitis A outbreaks.
Eurosurveillance latest updates
22.09.2023
On 5 April 2022, the United Kingdom reported an increase of cases of severe acute hepatitis of unknown aetiology in children, several needing hospitalisation and some required liver transplant or died. Thereafter, 35 countries reported probable cases, almost half of them in Europe. Facing the alert, on 28 April, Portugal created a multidisciplinary Task Force (TF) for rapid detection of probable cases and response. The experts of the TF came from various disciplines: clinicians, laboratory experts, epidemio…